NEW MJ NEWS

AbbVie to Host First-Quarter 2021 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its first-quarter 2021 financial results on Friday, April 30, 2021, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie’s Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:http://www.prnewswire.com/news-releases/abbvie-to-host-first-quarter-2021-earnings-conference-call-301258997.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$VHUB Announces New Product Is A Winner

Vapor Hub International’s New Product a Winner for Consumers and Company SIMI…

$GRCU announces launching of Rico Suave is on schedule

Green Cures & Botanical Distribution Inc. announces launching of Rico Suave is…

Transcanna Holdings Inc. (TCAN) (TCAN.CN) Receives Adelanto Adult Use Permits For Manufacturing and Distribution

TransCanna’s TCM Distribution, Inc. Receives Adelanto Adult Use Permits For Manufacturing and…

Maricann Group Inc. (MRRCF) Launches First Cannabidiol (CBD) Formulation Utilizing Patented Drug Delivery Technology in Germany

Maricann Launches First Cannabidiol (CBD) Formulation Utilizing Patented Drug Delivery Technology in…